Association Between Serum Cystatin C Level and Post-stroke Cognitive Impairment in Patients with Acute Mild Ischemic Stroke

Overview

Journal Brain Behav

Specialty Psychology

Date 2022 Feb 11

PMID 35148465

Authors

Xu Yan

Huan Chen

Xiu-Li Shang

Affiliations

Soon will be listed here.

Abstract

Background: Mild ischemic stroke (MIS) has been proved to be closely related to post-stroke cognitive impairment (PSCI). However, there are relatively few studies on the risk factors of MIS. We aimed to evaluate the relationship between serum cystatin C (CysC) level and cognitive function in patients with acute MIS.

Methods: Four hundred consecutive patients with acute MIS were screened and 281 patients were eligible for this study. The serum CysC levels were detected within 24 h after admission. Cognitive function was assessed by Montreal Cognitive Assessment (MoCA) at 3 months after acute MIS. Logistic regression was used to identify the predictors of PSCI, and the receiver operating characteristic (ROC) curve was applied to explore the optimal cut-off value.

Results: One hundred sixty-four (58.4%) patients were diagnosed with PSCI at 3 months follow-up. The serum CysC levels in patients with PSCI were significantly higher than patients without PSCI (p < .001). The binary logistic regression analysis showed that higher serum CysC level was an independent predictor for PSCI at 3 months (odds ratio [OR], 5.745; 95% confidence interval, [CI], 1.089-30.311; p = 0.039). The ROC curve showed that area under the curve (AUC) was 0.723, and at a 0.945 mg/l CysC cut-off point, the sensitivity and specificity for PSCI at 3 months were 79.9% and 58.1%, respectively.

Conclusion: Our findings suggested that the serum CysC levels were increased after acute MIS, and higher serum CysC levels at baseline might be an independent risk factor for PSCI in patients with acute MIS, but further research are warranted.

Citing Articles

Potential Biomarkers of Post-stroke Cognitive Impairment in Chinese Population: a Systematic Review and Meta-Analysis.

Jiang Z, Li M, Wang K, Duan H, Zhang B, Fang S Mol Neurobiol. 2025; .

PMID: 40032750 DOI: 10.1007/s12035-025-04792-x.

Research progress on the mechanism and markers of metabolic disorders in the occurrence and development of cognitive dysfunction after ischemic stroke.

Li H, Ke X, Feng B, Tian H, Cai Z, Zhang A Front Endocrinol (Lausanne). 2025; 16:1500650.

PMID: 39911922 PMC: 11794095. DOI: 10.3389/fendo.2025.1500650.

A comprehensive analysis of stroke risk factors and development of a predictive model using machine learning approaches.

Xie S, Peng S, Zhao L, Yang B, Qu Y, Tang X Mol Genet Genomics. 2025; 300(1):18.

PMID: 39853452 PMC: 11762205. DOI: 10.1007/s00438-024-02217-3.

Serum cystatin C and stroke risk: a national cohort and Mendelian randomization study.

Qi Y, Shang X, Han T, Han N, Jiang Z, Yan H Front Endocrinol (Lausanne). 2024; 15:1355948.

PMID: 38681764 PMC: 11045987. DOI: 10.3389/fendo.2024.1355948.

Lower glomerular filtration rate after mild stroke induces cognitive impairment by causing endothelial dysfunction.

Yan X, Chen H, Shang X Sci Rep. 2024; 14(1):6964.

PMID: 38521825 PMC: 10960789. DOI: 10.1038/s41598-024-57444-w.

References

Yue W, Wang A, Zhu R, Yan Z, Zheng S, Wang J . Association between Carotid Artery Stenosis and Cognitive Impairment in Stroke Patients: A Cross-Sectional Study. PLoS One. 2016; 11(1):e0146890. PMC: 4709110. DOI: 10.1371/journal.pone.0146890. View

Hamre C, Fure B, Helbostad J, Wyller T, Ihle-Hansen H, Vlachos G . Factors Associated with Level of Physical Activity After Minor Stroke. J Stroke Cerebrovasc Dis. 2021; 30(4):105628. DOI: 10.1016/j.jstrokecerebrovasdis.2021.105628. View

Yaffe K, Lindquist K, Shlipak M, Simonsick E, Fried L, Rosano C . Cystatin C as a marker of cognitive function in elders: findings from the health ABC study. Ann Neurol. 2008; 63(6):798-802. PMC: 2584446. DOI: 10.1002/ana.21383. View

Levy E, Jaskolski M, Grubb A . The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models. Brain Pathol. 2006; 16(1):60-70. PMC: 8095742. DOI: 10.1111/j.1750-3639.2006.tb00562.x. View

Lindsay M, Norrving B, Sacco R, Brainin M, Hacke W, Martins S . World Stroke Organization (WSO): Global Stroke Fact Sheet 2019. Int J Stroke. 2019; 14(8):806-817. DOI: 10.1177/1747493019881353. View

Inker L, Schmid C, Tighiouart H, Eckfeldt J, Feldman H, Greene T . Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012; 367(1):20-9. PMC: 4398023. DOI: 10.1056/NEJMoa1114248. View

Li X, Ma X, Lin J, He X, Tian F, Kong D . Severe carotid artery stenosis evaluated by ultrasound is associated with post stroke vascular cognitive impairment. Brain Behav. 2017; 7(1):e00606. PMC: 5256189. DOI: 10.1002/brb3.606. View

Fabjan T, Penko M, Hojs R . Newer glomerular filtration rate estimating equations for the full age spectrum based on serum creatinine and cystatin C in predicting mortality in patients with ischemic stroke. Eur J Intern Med. 2018; 52:67-72. DOI: 10.1016/j.ejim.2018.02.005. View

Sun J, Tan L, Yu J . Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med. 2014; 2(8):80. PMC: 4200648. DOI: 10.3978/j.issn.2305-5839.2014.08.05. View

10.

Roberts P, Krishnan S, Burns S, Ouellette D, Pappadis M . Inconsistent Classification of Mild Stroke and Implications on Health Services Delivery. Arch Phys Med Rehabil. 2020; 101(7):1243-1259. PMC: 7311258. DOI: 10.1016/j.apmr.2019.12.013. View

11.

Mijajlovic M, Pavlovic A, Brainin M, Heiss W, Quinn T, Ihle-Hansen H . Post-stroke dementia - a comprehensive review. BMC Med. 2017; 15(1):11. PMC: 5241961. DOI: 10.1186/s12916-017-0779-7. View

12.

Chen W, Pan Y, Zhao X, Liu L, Li H, Liao X . Intravenous Thrombolysis in Chinese Patients with Different Subtype of Mild Stroke: Thrombolysis in Patients with Mild Stroke. Sci Rep. 2017; 7(1):2299. PMC: 5442116. DOI: 10.1038/s41598-017-02579-2. View

13.

Kim T, Kang M, Jeong H, Kim C, Kim Y, Nam K . Cystatin C is a useful predictor of early neurological deterioration following ischaemic stroke in elderly patients with normal renal function. Eur Stroke J. 2019; 2(1):23-30. PMC: 6453184. DOI: 10.1177/2396987316677197. View

14.

Fabjan T, Penko M, Hojs R . Cystatin C, creatinine, estimated glomerular filtration, and long-term mortality in stroke patients. Ren Fail. 2013; 36(1):81-6. DOI: 10.3109/0886022X.2013.832314. View

15.

Sheikh A, Nagai A . An Improved Assay for Quantitation of Cerebrospinal Fluid Cystatin C Using Liquid Chromatography Tandem Mass Spectrometry. Methods Mol Biol. 2019; 2044:291-302. DOI: 10.1007/978-1-4939-9706-0_18. View

16.

Fang Z, Deng J, Wu Z, Dong B, Wang S, Chen X . Cystatin C Is a Crucial Endogenous Protective Determinant Against Stroke. Stroke. 2016; 48(2):436-444. DOI: 10.1161/STROKEAHA.116.014975. View

17.

Zeng Q, Huang Z, Wei L, Fang J, Lin K . Correlations of serum cystatin C level and gene polymorphism with vascular cognitive impairment after acute cerebral infarction. Neurol Sci. 2019; 40(5):1049-1054. DOI: 10.1007/s10072-019-03777-8. View

18.

Kono S, Adachi H, Enomoto M, Fukami A, Kumagai E, Nakamura S . Impact of cystatin C and microalbuminuria on cognitive impairment in the population of community-dwelling Japanese. Atherosclerosis. 2017; 265:71-77. DOI: 10.1016/j.atherosclerosis.2017.08.022. View

19.

Chao B, Yan F, Hua Y, Liu J, Yang Y, Ji X . Stroke prevention and control system in China: CSPPC-Stroke Program. Int J Stroke. 2020; 16(3):265-272. DOI: 10.1177/1747493020913557. View

20.

Ghidoni R, Benussi L, Glionna M, Desenzani S, Albertini V, Levy E . Plasma cystatin C and risk of developing Alzheimer's disease in subjects with mild cognitive impairment. J Alzheimers Dis. 2010; 22(3):985-91. DOI: 10.3233/JAD-2010-101095. View